|
Market Closed -
Swiss Exchange
01:31:17 19/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 115.10 CHF | -0.79% |
|
+2.73% | +5.02% |
| 19/09 | Novartis' Cosentyx Gets EU Medicines Agency Panel Recommendation for Polymyalgia Rheumatica | MT |
| 19/09 | Novartis Receives Positive Chmp Opinion for Cosentyx in Polymyalgia Rheumatica | CI |
| Market Cap | 266B 232B 219B 199B 372B 25,496B 374B 2,621B 1,011B 12,962B 998B 976B 41,708B | P/E 2026 * |
19.7x | P/E 2027 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise Value | 297B 259B 245B 222B 416B 28,526B 418B 2,932B 1,131B 14,503B 1,117B 1,092B 46,665B | EV / Sales 2026 * |
5.16x | EV / Sales 2027 * | 4.79x |
| Free-Float |
91.66% | Yield 2026 * |
3.11% | Yield 2027 * | 3.25% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
London S.E.
| 0QLR | Delayed | |
|
CBOE
| 0QLR | Real-time | |
|
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
Tradegate
| NOT | Real-time | |
|
Boerse Muenchen
| NOT | Real-time | |
|
Xetra
| NOT | End-of-day quote | |
|
Xetra
| NOT | Delayed | |
|
OTC Markets
| NVSEF | Delayed | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Börse Stuttgart
| NOT | Delayed | |
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
CBOE
| 0QLR | Real-time | |
|
Wiener Boerse
| NOVN | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | -0.79% | ||
| 1 week | +2.73% | ||
| Current month | -6.62% | ||
| 1 month | -9.46% | ||
| 3 months | -2.70% | ||
| 6 months | -1.52% | ||
| Current year | +5.02% |
| 1 week | 112.46 |  | 116.98 |
| 1 month | 110.3 | | 132.68 |
| Current year | 107.68 | | 132.68 |
| 1 year | 96.8 | | 132.68 |
| 3 years | 81.1 | | 132.68 |
| 5 years | 72.84 | | 132.68 |
| 10 years | 65.09 | | 132.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 14/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/5/26 | Sell | -5,200 | 0.0003% | |||
| 4/5/26 | Sell | 6,800 | 0.0003% | |||
| 17/2/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.79% | +2.73% | +17.73% | +25.11% | 266B | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | |
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | |
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | |
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | |
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | |
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | |
| +0.07% | -0.22% | +15.11% | -18.62% | 158B | |
| Average | +0.04% | +2.91% | +24.24% | +38.95% | 375.94B | |
| Weighted average by Cap. | -0.03% | +2.95% | +34.02% | +58.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.65B 50.27B 47.47B 43.1B 80.76B 5,532B 81.1B 569B 219B 2,813B 217B 212B 9,050B | 61.33B 53.48B 50.5B 45.86B 85.92B 5,885B 86.28B 605B 233B 2,992B 230B 225B 9,627B |
| Net income | 14.2B 12.38B 11.69B 10.61B 19.89B 1,362B 19.97B 140B 54.03B 693B 53.33B 52.14B 2,228B | 15.75B 13.74B 12.97B 11.78B 22.07B 1,512B 22.16B 155B 59.96B 769B 59.18B 57.86B 2,473B |
| Net Debt | 31.58B 27.54B 26B 23.61B 44.24B 3,030B 44.42B 311B 120B 1,541B 119B 116B 4,957B | 27.89B 24.32B 22.96B 20.85B 39.06B 2,676B 39.23B 275B 106B 1,360B 105B 102B 4,377B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | CHF 115.10 | -0.79% | 8,399,187 |
| 17/09/26 | CHF 116.02 | +1.52% | 2,407,734 |
| 16/09/26 | CHF 114.28 | +0.39% | 4,101,101 |
| 15/09/26 | CHF 113.84 | -0.07% | 3,954,861 |
| 14/09/26 | CHF 113.92 | +1.68% | 3,025,084 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
